2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran has been researched along with edelfosine in 2 studies
| Studies (2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran) | Trials (2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran) | Recent Studies (post-2010) (2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran) | Studies (edelfosine) | Trials (edelfosine) | Recent Studies (post-2010) (edelfosine) |
|---|---|---|---|---|---|
| 63 | 0 | 0 | 454 | 7 | 85 |
| Protein | Taxonomy | 2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran (IC50) | edelfosine (IC50) |
|---|---|---|---|
| Platelet-activating factor receptor | Cavia porcellus (domestic guinea pig) | 1.8 | |
| RAC-alpha serine/threonine-protein kinase | Homo sapiens (human) | 3.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bazill, GW; Dexter, TM | 2 |
2 other study(ies) available for 2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran and edelfosine
| Article | Year |
|---|---|
Role of endocytosis in the action of ether lipids on WEHI-3B, HL60, and FDCP-mix A4 cells.
Topics: Animals; Antineoplastic Agents; Azepines; Cell Survival; Chloroquine; Diltiazem; Drug Synergism; Endocytosis; Furans; Humans; Hydroxyzine; In Vitro Techniques; Leukemia, Myeloid; Mice; Nifedipine; Phospholipid Ethers; Platelet Activating Factor; Pyridines; Quinidine; Quinine; Sodium Fluoride; Thiazoles; Triazoles; Verapamil | 1990 |
An antagonist to platelet activating factor counteracts the tumoricidal action of alkyl lysophospholipids.
Topics: Biological Transport; Cell Survival; Furans; Phospholipid Ethers; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Tumor Cells, Cultured | 1989 |